Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Galapagos starts Phase IIa trial of GLPG1690 for systemic sclerosis

Micrograph of lichen sclerosus. Credit: Nephron.



  • Galapagos

Go Top